The optimal selection and use of adrenergic-blocking agents in the cardiovascular continuum will assist in providing improved management while minimizing safety and tolerability concerns.

In this review the authors demonstrate the pivotal role of angiotensin II in the development of the cardiovascular continuum and evaluate the effects of complete inhibition of the RAS on vascular ...

Researchers from Imperial College London have developed a new artificial intelligence (AI) model capable of identifying ...

This provides a continuum of care for patients with congenital heart disease and allows our multidisciplinary team of specialists to move efficiently from one end of the platform to the other. The ...